Publicações

Efficacy and Safety of Ct-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase Iii Study

AuthID
P-00V-MMA

Author(s)

Kwak, LW

Sancho, JM

Cho, SG

Nakazawa, H

Suzumiya, J

Tumyan, G

Kim, JS

Menne, T

[+3]·

Ruiz, EY

Popplewell, L

Ogura, M

Kim, WS

Lee, SJ

Kim, SH

Ahn, KY

Buske, C

View all authors

Tipo de Documento

Article

Year published

2022

Publicado

in CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, ISSN: 2152-2650

Volume: 22, Número: 2, Páginas: 89-97 (9)

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1016/j.clml.2021.08.005

Pubmed: 34686445

SCOPUS: 2-s2.0-85118188377

Wos: WOS:000757000400013

Source Identifiers

ISSN: 2152-2650

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

All authors

Name Order	Nome	Name Order	Nome	Name Order	Nome
1	Kwak, LW;	2	Sancho, JM;	3	Cho, SG;
4	Nakazawa, H;	5	Suzumiya, J;	6	Tumyan, G;
7	Kim, JS;	8	Menne, T;	9	Mariz, J;
10	Ilyin, N;	11	Jurczak, W;	12	Martinez, AL;
13	Samoilova, O;	14	Zhavrid, E;	15	Ruiz, EY;
16	Trneny, M;	17	Popplewell, L;	18	Ogura, M;
19	Kim, WS;	20	Lee, SJ;	21	Kim, SH;
22	Ahn, KY;	23	Buske, C;

Efficacy and Safety of Ct-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase Iii Study

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Efficacy and Safety of Ct-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase Iii Study

Links Úteis

Ajuda